Histology is the study of the microscopic structure of tissues. In a histology lab, an anatomical pathologist attempts to identify the causes and consequences of disease in a specific part of the body. This is done by examining tissue samples with a powerful microscope used to identify structural and other changes in cells tissues and organs.

Anatomical pathology examinations are among the most reliable ways to establish:

Cytology is the microscopic study of the function and structure of individual cells. In a cytology lab, a cytopathologist identifies and diagnoses disease by studying human cells that have been collected either by a brush or wash, as is the case in liquid-based pap collection, and ductal lavage specimens, or in fine needle aspirates, that are taken from various parts of the body.

Cytotechnologists microscopically examine the morphology of individual cells, view these impressions in the context of a patient's own history, and give an opinion as to the overall impression. Cytopathologists review all slides for final interpretation.

Cytologic interpretation aids the clinician with patient diagnosis, assists with patient management, and allows for follow up the success of therapy.

Ventana's instruments allow for standardized and reproducible staining of a variety of cytologic specimens.

Drug Research

There are over a half a million researchers worldwide each with the desire to make a difference by determining the cause of diseases and discovering drugs to treat them. Both genomics, the study of genes and their function, and proteomics, the study of proteins and their function, seek to accelerate the drug discovery process by understanding the underlying molecular mechanisms of disease.

Ventana Medical System's Work in Drug Research and Development

Recent advances in the human genome project and their impact on the field of drug discovery have created several growth opportunities for Ventana Medical Systems. Our automated instrumentation and reagent systems are used by leading pharmaceutical and biotechnology companies to speed the discovery of new drug targets.